Mod GRF 1-29 & GHRP-6 Blend
A research blend pairing Mod GRF 1-29 (CJC-1295 no DAC) with GHRP-6 for synergistic GH release while preserving physiological pulse patterns.
Community Rating
No ratings yet
⚠ Research & Educational Use Only. Mod GRF 1-29 & GHRP-6 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Synergistic GH pulses preserving physiological pulsatility
- Mod GRF 1-29 DPP-IV resistance for improved duration vs native GHRH
- GHRP-6 appetite stimulation alongside GH release
- Mod GRF 1-29 & GHRP-6 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Synergistic GH pulses preserving physiological pulsatility
- Mod GRF 1-29 DPP-IV resistance for improved duration vs native GHRH
- GHRP-6 appetite stimulation alongside GH release
- Well-studied combination in research protocols
What is Mod GRF 1-29 & GHRP-6 Blend?
Tap any underlined term for an instant definition.
The Mod GRF 1-29 & GHRP-6 Blend pairs Modified GRF 1-29 (CJC-1295 without DAC) with GHRP-6. Unlike CJC-1295 with DAC, Mod GRF 1-29 has a half-life of 30-60 minutes, producing physiological GH pulses rather than continuous GH elevation. This is the most commonly referenced protocol in peer-reviewed research combining GHRH analogues and GHSPs.
What It Is
- Mod GRF 1-29: GHRH 1-29 with four amino acid substitutions for DPP-IV resistance; half-life ~30-60 min
- GHRP-6: GHS-R1a + motilin receptor agonist; strong appetite-stimulating GHS
- Preferred by researchers who want synergistic GH release in physiological pulses (vs sustained elevation with DAC)
- Historically one of the most-cited research GHRH + GHRP combinations
How It Works
- Mod GRF 1-29 activates GHRHR with improved stability vs native GHRH
- GHRP-6 simultaneously activates GHS-R1a and suppresses somatostatin
- Combined GH pulses: 3-4x either peptide alone; pulse decays naturally within 3 hours
- GHRP-6 appetite effect can be used to time nutrient delivery post-GH pulse
Key Research Findings
- This exact combination is referenced in the majority of community research protocols
- GH amplitude comparable to other GHRH + GHRP combinations (40-60 ng/mL peak in responsive subjects)
- Twice-daily dosing maintains physiological pulsatility without receptor downregulation
Dosing From the Literature
- Mod GRF 1-29 100-200 mcg + GHRP-6 100-200 mcg per injection
- 2-3 times daily, with at least 3 hours between doses
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Mod GRF 1-29 & GHRP-6 Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection on empty stomach. GHRP-6 appetite effect makes pre-meal timing useful.
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-2 Blend
- Sermorelin & GHRP-6 Blend
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.